CALL US: 206.533.3854
CALL US  206.533.3854
AEON Law logo full color transparent
By Peter Newell - Michigan State University LibrariesImage pageFables for the Frivolous main pageMichigan State University Libraries home page, Public Domain, https://commons.wikimedia.org/w/index.php?curid=2208251

Do Patent Examiners Reject Applications for “Frivolous” Reasons?

E-Commerce Patent
Rejections Higher than Most.
Reasons Frivolous?

The overall allowance rate for US patent applications generally is 55.8%, based on a 2013 report by the US Patent Office.

However, the allowance rate varies widely based on the “Art Unit” involved.

An “Art Unit” describes the type of technology at issue. For example, Art Unit 1764 is for “BLEACHING AND DYEING; FLUID TREATMENT AND CHEMICAL MODIFICATION OF TEXTILES AND FIBERS.”

A recent study found that the allowance rates for Art Units 3689 and 3622 were “extraordinarily low.”

These e-commerce-related Art Units cover aspects of “DATA PROCESSING: FINANCIAL, BUSINESS PRACTICE, MANAGEMENT, OR COST/PRICE DETERMINATION.”

Only 12 patents were issued for Art Unit 3689 in 2015, and 365 applications were abandoned. This yields an allowance rate of 3.2%.

For Art Unit 3622 the rate was 5.6%.

For 2016, the rates are even lower, with 1.3% for Art Unit 3689.

According to the IPWatchdog blog,

Patent examiners in various E-commerce Art Units have been telling patent attorneys and patent agents for many years that their supervisors require them to issue rejections in all cases, even going as far as to tell attorneys that they have been instructed to come up with ridiculous, bogus, frivolous rejections that clearly have no merit. Over the years this has caused some examiners to quit, choosing to leave the Patent Office altogether rather than participate in this charade.

When the Patent Office rejects a patent application, the patent applicant can appeal to the Patent Trial and Appeal Board (PTAB).

The PTAB can then send the matter back to the examiner to issue the patent.

However, sometimes the patents are still not issued.

37 CFR 1.198 says that:

prosecution of the proceeding before the primary examiner will not be reopened or reconsidered by the primary examiner … without the written authority of the Director, and then only for the consideration of matters not already adjudicated, sufficient cause being shown.

This should be a very rare procedure. However, in the case of the Art Units in the 3600 series, in 11 cases in the last 10 months prosecutions have been reopened after PTAB decisions reversing the examiners’ rejections.

In summary, it seems like the Patent Office is going out of its way to avoid the issuance of patents in the e-commerce space.

This is a troubling trend for patent applicants.

Related Articles

Patent and Trademark Offices Publish Study on NFT IP Issues

The US Patent and Trademark Office (USPTO) and the Copyright Office have published the results of their joint study on non-fungible tokens (NFTs) and intellectual property (IP). ...
Read More

Fourth Circuit Overturns $1 Billion Copyright Infringement Verdict

The Fourth Circuit has overturned a $1 billion verdict in a copyright case against Cox Communications. As the court explained, Defendant Cox Communications sells internet, ...
Read More

Will Federal Circuit Soften Test for Design Patent Obviousness?

An en banc panel of the Federal Circuit recently heard arguments in a case that could change how courts assess design patents for “obviousness.” LKQ ...
Read More

Let's work together.

Contact us to set up a meeting with an attorney or team member.

Stay Informed

Sign up to receive Patent Poetry—a monthly roundup of key IP issues in our signature haiku format. Four articles (only 68 syllables); zero hassle.

SECTORS

HIGH
TECHNOLOGY

Artificial Intelligence

Blockchain & Cryptocurrency

Computer Technology & Software

Consumer Electronics

Electrical Devices

MECHANICAL
& PRODUCTS​

Cleantech

Mechanical Devices

Consumer & Retail Products

Hardware & Tools

Toys & Games

LIFE SCIENCES
& CHEMISTRY​

Biotechnology

Chemical Compounds

Digital Health

Healthcare Products

Pharmaceuticals

BRANDING
& CREATIVE​

Books & Publications

Brand Creation

Luxury Products

Photography & Video

Product Design

SERVICES

PROTECT

DEAL

DEFEND